Germany becoming the "wild card" in drug pricing

Dear Readers,

just saw this in the news (see link below). Germany is thinking of issuing a new law that the so far confidential price discounts be made public. That would be an entire new ballgame for the industry in Europe with potentially significant price erosions and spillover effects elsewhere.

Will keep an eye on that.



1 comment:

Obgyn mountain view, ca said...

What a great things you shared for me here.